Moto Yaga

415 total citations
13 papers, 160 citations indexed

About

Moto Yaga is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Moto Yaga has authored 13 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Moto Yaga's work include Lung Cancer Treatments and Mutations (4 papers), CAR-T cell therapy research (3 papers) and Lung Cancer Research Studies (3 papers). Moto Yaga is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), CAR-T cell therapy research (3 papers) and Lung Cancer Research Studies (3 papers). Moto Yaga collaborates with scholars based in Japan. Moto Yaga's co-authors include Kentaro Masuhiro, Hiroshi Kida, Atsushi Kumanogoh, Kota Iwahori, Yoshito Takeda, Haruhiko Hirata, Izumi Nagatomo, Yuya Shirai, Kotaro Miyake and Shohei Koyama and has published in prestigious journals such as Scientific Reports, Cancer Immunology Immunotherapy and Supportive Care in Cancer.

In The Last Decade

Moto Yaga

8 papers receiving 159 citations

Peers

Moto Yaga
Damien Vansteene France
Jeroen W. G. Derksen Netherlands
Baomin Zheng China
Kareem Fakhoury United States
Valentine Heidelberger France
Bénédicte Gelas‐Dore France
Simon McCluney United Kingdom
Gayle C. Blouin United States
Leonor Vasconcelos de Matos Portugal
Vittorio Baggio Italy
Damien Vansteene France
Moto Yaga
Citations per year, relative to Moto Yaga Moto Yaga (= 1×) peers Damien Vansteene

Countries citing papers authored by Moto Yaga

Since Specialization
Citations

This map shows the geographic impact of Moto Yaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moto Yaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moto Yaga more than expected).

Fields of papers citing papers by Moto Yaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moto Yaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moto Yaga. The network helps show where Moto Yaga may publish in the future.

Co-authorship network of co-authors of Moto Yaga

This figure shows the co-authorship network connecting the top 25 collaborators of Moto Yaga. A scholar is included among the top collaborators of Moto Yaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moto Yaga. Moto Yaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Kuroda, Hideki, Noriyuki Kijima, Shunya Ikeda, et al.. (2025). Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma. Cancer Immunology Immunotherapy. 74(4). 136–136.
3.
4.
Kijima, Noriyuki, Hideki Kuroda, Moto Yaga, et al.. (2024). Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model. Cancer Immunology Immunotherapy. 73(12). 256–256. 8 indexed citations
5.
6.
Komukai, Sho, Tomoaki Hoshino, Kentaro Masuhiro, et al.. (2023). Identifying phenotypes in interstitial lung disease using group-based trajectory modelling. The International Journal of Tuberculosis and Lung Disease. 27(4). 332–334.
7.
Miyake, Kotaro, Izumi Nagatomo, Takayuki Shiroyama, et al.. (2022). Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing. Scientific Reports. 12(1). 19774–19774. 2 indexed citations
8.
Kijima, Noriyuki, Kana Hasegawa, Shunya Ikeda, et al.. (2022). Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy. Neuro-Oncology Advances. 5(1). vdac177–vdac177. 7 indexed citations
9.
Yaga, Moto, et al.. (2021). Lipoid Pneumonia After Pembrolizumab Treatment for Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 23(2). e116–e117.
10.
Shiroyama, Takayuki, Izumi Nagatomo, Shohei Koyama, et al.. (2019). Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study. Scientific Reports. 9(1). 2447–2447. 126 indexed citations
11.
Koba, Taro, Seigo Minami, Kentaro Masuhiro, et al.. (2018). Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 82(1). 111–117. 2 indexed citations
12.
Fujimoto, Kosuke, Seigo Minami, Suguru Yamamoto, et al.. (2014). Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital. Supportive Care in Cancer. 22(6). 1485–1492. 12 indexed citations
13.
Minami, Seigo, Masanari Hamaguchi, Suguru Yamamoto, et al.. (2014). Small-cell lung cancer: a case report on the manifestation of paraneoplastic motor neuron disease after effective tumor shrinkage during chemotherapy. International Cancer Conference Journal. 3(4). 247–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damien Vansteene Breakdown of academic impact, for papers by Jeroen W. G. Derksen Breakdown of academic impact, for papers by Baomin Zheng Breakdown of academic impact, for papers by Kareem Fakhoury Breakdown of academic impact, for papers by Valentine Heidelberger Breakdown of academic impact, for papers by Bénédicte Gelas‐Dore Breakdown of academic impact, for papers by Simon McCluney Breakdown of academic impact, for papers by Gayle C. Blouin Breakdown of academic impact, for papers by Leonor Vasconcelos de Matos Breakdown of academic impact, for papers by Vittorio Baggio
Rankless by CCL
2026